TCM
MDGL icon

Tao Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Tao Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Hold
21,000
– – 9.25% 4
2025
Q4 		$12.2M Sell
21,000
-20,000
-49% -$10.2M 10.53% 4
2025
Q3 		$18.8M Sell
41,000
-71,785
-64% -$26.8M 14.22% 4
2025
Q2 		$34.1M Hold
112,785
– – 25.03% 1
2025
Q1 		$37.4M Sell
112,785
-17,744
-14% -$5.83M 32.17% 1
2024
Q4 		$40.3M Hold
130,529
– – 28.11% 1
2024
Q3 		$27.7M Hold
130,529
– – 25.09% 2
2024
Q2 		$36.6M Hold
130,529
– – 29.98% 2
2024
Q1 		$34.9M Hold
130,529
– – 33.02% 1
2023
Q4 		$30.2M Buy
130,529
+52,872
+68% +$9.25M 27.63% 2
2023
Q3 		$11.3M Hold
77,657
– – 8.78% 4
2023
Q2 		$17.9M Hold
77,657
– – 13.14% 3
2023
Q1 		$18.8M Hold
77,657
– – 14.97% 2
2022
Q4 		$22.5M Hold
77,657
– – 16.95% 2
2022
Q3 		$5.05M Hold
77,657
– – 3.31% 9
2022
Q2 		$5.56M Hold
77,657
– – 3.85% 8
2022
Q1 		$7.62M Hold
77,657
– – 2.78% 9
2021
Q4 		$6.58M Buy
77,657
+26,261
+51% +$2.16M 2.01% 10
2021
Q3 		$4.1M Hold
51,396
– – 1.09% 10
2021
Q2 		$5.01M Hold
51,396
– – 1.15% 9
2021
Q1 		$6.01M Hold
51,396
– – 1.74% 6
2020
Q4 		$5.71M Hold
51,396
– – 1.41% 5
2020
Q3 		$6.1M Buy
+51,396
New +$5.58M 1.97% 4

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tao Capital Management's MDGL Position: Q1 2026 in Review

Tao Capital Management held its Madrigal Pharmaceuticals (MDGL) position steady in Q1 2026 at 21,000 shares worth $11M. The position accounts for 9.25% of the portfolio, ranked #4.

Tao Capital Management first reported a position in MDGL in Q3 2020 and has held it in 23 quarters since. The position peaked at $40.3M in Q4 2024. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Tao Capital Management held 21,000 shares of Madrigal Pharmaceuticals worth $11M as of Q1 2026.
  • Tao Capital Management left its Madrigal Pharmaceuticals share count unchanged in Q1 2026.
  • Madrigal Pharmaceuticals made up 9.25% of Tao Capital Management's portfolio in Q1 2026, its #4 holding.
  • Tao Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Tao Capital Management's Madrigal Pharmaceuticals position peaked at $40.3M in Q4 2024.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Tao Capital Management's 13F filing for Q1 2026, filed 14 May 2026.